{"id":9324,"date":"2023-02-13T09:58:11","date_gmt":"2023-02-13T08:58:11","guid":{"rendered":"https:\/\/www.marchebiobank.it\/progetto-regione-marche\/?p=9324"},"modified":"2023-02-13T10:05:51","modified_gmt":"2023-02-13T09:05:51","slug":"3d-printed-eva-based-patches-manufactured-by-direct-powder-extrusion-for-personalized-transdermal-therapies","status":"publish","type":"post","link":"https:\/\/www.marchebiobank.it\/progetto-regione-marche\/3d-printed-eva-based-patches-manufactured-by-direct-powder-extrusion-for-personalized-transdermal-therapies\/","title":{"rendered":"3D-printed EVA-based patches manufactured by direct powder extrusion for personalized transdermal therapies"},"content":{"rendered":"\n<p class=\"has-text-align-center\">This document is the Submitted Manuscript version of a Published article 1 that appeared in final form in see<br>International Journal of Pharmaceutics, copyright ELSEVIER.<br>To access the final edited and published work see: <a rel=\"noreferrer noopener\" href=\"https:\/\/doi.org\/10.1016\/j.ijpharm.2023.122720\" target=\"_blank\">https:\/\/doi.org\/10.1016\/j.ijpharm.2023.122720<\/a><\/p>\n\n\n\n<p class=\"has-text-align-left\"><strong>3D-printed EVA-based patches manufactured by direct powder extrusion for personalized transdermal therapies<\/strong><br>Giorgia Maurizii<sup>1<\/sup>, Sofia Moroni<sup>1<\/sup>, Shiva Khorshid<sup>1<\/sup>, Annalisa Aluigi<sup>1<\/sup>, Mattia Tiboni<sup>1<\/sup>*, and Luca<br>Casettari<sup>1,2<\/sup><br><sup>1<\/sup>Department of Biomolecular Sciences, University of Urbino Carlo Bo, Piazza del Rinascimento, 6, 61029 Urbino<br>(PU), Italy.<br><sup>2<\/sup> Prosopika srl, Via del Trabocchetto, 1, 61034, Fossombrone (PU), Italy.<\/p>\n\n\n\n<p>Sofia Moroni acknowledge Marche Region for the PhD scholarship (Innovative doctoral programme POR<br>Marche FSE 2014\/2020 D.R. 354\/2020).<br>This research received funding from Regione Marche (Italy) POR MARCHE FESR 2014\u20132020 &#8211; Asse 1 \u2013 OS<br>Azione 2.1\u00a0<br>Si ringrazia la <a rel=\"noreferrer noopener\" href=\"https:\/\/www.regione.marche.it\/\" target=\"_blank\">Regione Marche<\/a> per aver finanziato la borsa di Sofia Moroni attraverso i Dottorati Innovativi.<\/p>\n\n\n\n<p><strong>Abstract<\/strong><br>In recent years, 3D printing has attracted great interest in the pharmaceutical field as a promising tool for the<br>on-demand manufacturing of patient-centered pharmaceutical forms. Among the existing 3D printing<br>techniques, direct powder extrusion (DPE) has been demonstrated as the most practical approach thanks to its<br>high flexibility, low cost, and simplicity. The main goal of this work was to determine whether different grades<br>of ethylene vinyl acetate (EVA) copolymer might be employed as new feedstock materials for the DPE<br>technique to manufacture transdermal patches. By selecting two model drugs with different thermal behavior,<br>we also wanted to pay attention to the versatility of EVA excipient in preparing patches for customized<br>transdermal therapies. EVA polymeric matrices were loaded with 30% (w\/w) of the model drug. Both<br>formulations were successfully processed with the DPE technique. The physicochemical composition of the<br>printed devices was investigated through Fourier-transform infrared spectroscopy, differential scanning<br>calorimetry, and thermogravimetric analyses. Lastly, the drug release and permeation profile of the printed<br>systems was evaluated for 48 hours and showed to be dependent on the VA content of the EVA grade. Hence,<br>this study demonstrated that EVA and direct powder extrusion technique could be promising tools for<br>manufacturing transdermal patches. By selecting the EVA grade with the appropriate VA content, drugs with<br>dissimilar melting points could be printed preserving their thermal stability. Moreover, the desired drug release<br>and permeation profile of the drug can be achieved, representing an important advantage in terms of<br>personalized medicine.<\/p>\n\n\n\n<p><br><strong>Keywords<\/strong>: Direct Powder Extrusion (DPE); Ethyl vinyl acetate (EVA) copolymer; Transdermal patches;<br>Personalized medicine; Additive manufacturing<\/p>\n\n\n\n<p><\/p>\n\n\n\n<div class=\"wp-block-file\"><a href=\"https:\/\/www.marchebiobank.it\/progetto-regione-marche\/wp-content\/uploads\/2023\/02\/2023_UNIURB_Prosopika_3D-printed-EVA-based-patches-manufactured-by-direct-powder-extrusion-for-personalized-transdermal-therapies.pdf\">2023_UNIURB_Prosopika_3D-printed-EVA-based-patches-manufactured-by-direct-powder-extrusion-for-personalized-transdermal-therapies<\/a><a href=\"https:\/\/www.marchebiobank.it\/progetto-regione-marche\/wp-content\/uploads\/2023\/02\/2023_UNIURB_Prosopika_3D-printed-EVA-based-patches-manufactured-by-direct-powder-extrusion-for-personalized-transdermal-therapies.pdf\" class=\"wp-block-file__button\" download>Download<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>This document is the Submitted Manuscript version of a Published article 1 that appeared in final form in seeInternational Journal of Pharmaceutics, copyright ELSEVIER.To access the final edited and published work see: https:\/\/doi.org\/10.1016\/j.ijpharm.2023.122720 3D-printed EVA-based patches manufactured by direct powder extrusion for personalized transdermal therapiesGiorgia Maurizii1, Sofia Moroni1, Shiva Khorshid1, Annalisa Aluigi1, Mattia Tiboni1*, and &hellip; <a href=\"https:\/\/www.marchebiobank.it\/progetto-regione-marche\/3d-printed-eva-based-patches-manufactured-by-direct-powder-extrusion-for-personalized-transdermal-therapies\/\" class=\"more-link\">Continue reading <span class=\"screen-reader-text\">3D-printed EVA-based patches manufactured by direct powder extrusion for personalized transdermal therapies<\/span><\/a><\/p>\n","protected":false},"author":7,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[245],"tags":[],"_links":{"self":[{"href":"https:\/\/www.marchebiobank.it\/progetto-regione-marche\/wp-json\/wp\/v2\/posts\/9324"}],"collection":[{"href":"https:\/\/www.marchebiobank.it\/progetto-regione-marche\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marchebiobank.it\/progetto-regione-marche\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marchebiobank.it\/progetto-regione-marche\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marchebiobank.it\/progetto-regione-marche\/wp-json\/wp\/v2\/comments?post=9324"}],"version-history":[{"count":2,"href":"https:\/\/www.marchebiobank.it\/progetto-regione-marche\/wp-json\/wp\/v2\/posts\/9324\/revisions"}],"predecessor-version":[{"id":9328,"href":"https:\/\/www.marchebiobank.it\/progetto-regione-marche\/wp-json\/wp\/v2\/posts\/9324\/revisions\/9328"}],"wp:attachment":[{"href":"https:\/\/www.marchebiobank.it\/progetto-regione-marche\/wp-json\/wp\/v2\/media?parent=9324"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marchebiobank.it\/progetto-regione-marche\/wp-json\/wp\/v2\/categories?post=9324"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marchebiobank.it\/progetto-regione-marche\/wp-json\/wp\/v2\/tags?post=9324"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}